Bruce Feinberg, DO: Hello, and welcome to this AJMC® Peer Exchange program titled “Oral Therapy Considerations for the Management of Myelodysplastic Syndromes.” I’m Dr Bruce Feinberg, vice president ...

Frontline staff in long-term care facilities generally do not have a firm grasp on Minimum Data Set Quality Indicators, largely due to a lack of involvement with the MDS, according to a recently ...

How are myelodysplastic syndromes diagnosed and staged? What causes them? An expert from Moffit Cancer Center offers insight. Myelodysplastic syndromes, known commonly as MDS, are a group of bone ...

Myelodysplastic syndrome is an extremely heterogeneous disease, and there is no definitive cure, so these investigators wanted a better understanding of patients’ priorities regarding their care, ...

Due to the extremely rare overlap of mitochondrial DNA depletion syndrome type 3 and pediatric hepatocellular carcinoma, the case presents daunting therapeutic challenges.

Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In this video with Healio.com, Rafael ...

According to Ira Zackon, MD, a hematologist-oncologist and senior medical director at Ontada, a retrospective study of over ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Probably the most critical complication in ...